PWPS
FOLD

Pinnacle Wealth Planning Services’s Amicus Therapeutics FOLD Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.4K Hold
994
– – ﹤0.01% 1854
2025
Q4 		$14.2K Buy
+994
New +$9.77K ﹤0.01% 1872
2021
Q1 		– Sell
-4,009
Closed -$93K – 936
2020
Q4 		$93K Buy
+4,009
New +$82K 0.02% 503

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Pinnacle Wealth Planning Services's FOLD Position: Q1 2026 in Review

Pinnacle Wealth Planning Services held its Amicus Therapeutics (FOLD) position steady in Q1 2026 at 994 shares worth $14.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1854.

Pinnacle Wealth Planning Services first reported a position in FOLD in Q4 2020 and has held it in 3 quarters since. The position peaked at $93K in Q4 2020. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Pinnacle Wealth Planning Services held 994 shares of Amicus Therapeutics worth $14.4K as of Q1 2026.
  • Pinnacle Wealth Planning Services left its Amicus Therapeutics share count unchanged in Q1 2026.
  • Amicus Therapeutics made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q1 2026, its #1854 holding.
  • Pinnacle Wealth Planning Services first reported a position in Amicus Therapeutics in Q4 2020 and has held it in 3 quarters since.
  • Pinnacle Wealth Planning Services's Amicus Therapeutics position peaked at $93K in Q4 2020.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q1 2026, filed 11 May 2026.